| Dr Claudia Therese Sickinger, MD | |
|
121 Westmoreland Ave, White Plains, NY 10606-2323 | |
| (914) 949-9300 | |
| (914) 328-3166 |
| Full Name | Dr Claudia Therese Sickinger |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 29 Years |
| Location | 121 Westmoreland Ave, White Plains, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053534115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0015X | Psychiatry & Neurology - Psychosomatic Medicine | 203643 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Contemporary Care Llc | 9537408141 | 18 |
News Archive
Scientists from the New York Stem Cell Foundation Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering.
Pepscan Therapeutics, the Dutch biotechnology firm focusing on protein mimicry technology, today announces that it has signed a Research and License Agreement with Crucell Holland B.V. the Dutch developer of vaccines and antibodies.
Massachusetts' 2009 ban on ambulance diversion not only did not increase emergency department length of stay or ambulance turnaround time but may actually have led to improvements in both areas, according to a study published online today in Annals of Emergency Medicine ("The Effect of an Ambulance Diversion Ban on Emergency Department Length of Stay and Ambulance Turnaround Time").
The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.
Could preventing colon cancer be as simple as developing a taste for yerba mate tea? In a recent University of Illinois study, scientists showed that human colon cancer cells die when they are exposed to the approximate number of bioactive compounds present in one cup of this brew, which has long been consumed in South America for its medicinal properties.
› Verified 4 days ago
| Entity Name | Contemporary Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639734338 PECOS PAC ID: 9537408141 Enrollment ID: O20190517001673 |
News Archive
Scientists from the New York Stem Cell Foundation Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering.
Pepscan Therapeutics, the Dutch biotechnology firm focusing on protein mimicry technology, today announces that it has signed a Research and License Agreement with Crucell Holland B.V. the Dutch developer of vaccines and antibodies.
Massachusetts' 2009 ban on ambulance diversion not only did not increase emergency department length of stay or ambulance turnaround time but may actually have led to improvements in both areas, according to a study published online today in Annals of Emergency Medicine ("The Effect of an Ambulance Diversion Ban on Emergency Department Length of Stay and Ambulance Turnaround Time").
The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.
Could preventing colon cancer be as simple as developing a taste for yerba mate tea? In a recent University of Illinois study, scientists showed that human colon cancer cells die when they are exposed to the approximate number of bioactive compounds present in one cup of this brew, which has long been consumed in South America for its medicinal properties.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Claudia Therese Sickinger, MD 265 Dans Hwy, New Canaan, CT 06840-2506 Ph: (203) 966-9599 | Dr Claudia Therese Sickinger, MD 121 Westmoreland Ave, White Plains, NY 10606-2323 Ph: (914) 949-9300 |
News Archive
Scientists from the New York Stem Cell Foundation Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering.
Pepscan Therapeutics, the Dutch biotechnology firm focusing on protein mimicry technology, today announces that it has signed a Research and License Agreement with Crucell Holland B.V. the Dutch developer of vaccines and antibodies.
Massachusetts' 2009 ban on ambulance diversion not only did not increase emergency department length of stay or ambulance turnaround time but may actually have led to improvements in both areas, according to a study published online today in Annals of Emergency Medicine ("The Effect of an Ambulance Diversion Ban on Emergency Department Length of Stay and Ambulance Turnaround Time").
The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.
Could preventing colon cancer be as simple as developing a taste for yerba mate tea? In a recent University of Illinois study, scientists showed that human colon cancer cells die when they are exposed to the approximate number of bioactive compounds present in one cup of this brew, which has long been consumed in South America for its medicinal properties.
› Verified 4 days ago
Dr. Mina Oza, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 311 North St Ste 201, White Plains, NY 10605 Phone: 914-639-3100 Fax: 914-639-3101 | |
Virginia L Susman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 21 Bloomingdale Rd, White Plains, NY 10605 Phone: 914-997-5865 Fax: 914-997-4340 | |
Dr. Qamrun Abedin, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 69 Greenvale Cir, White Plains, NY 10607 Phone: 914-831-9155 | |
Dr. Sharon D Neeman, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 41 E Post Rd, Departmet Of Behavioral Health, White Plains, NY 10601 Phone: 914-681-2573 | |
Dr. Maria De Pena-nowak, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 21 Bloomingdale Rd, White Plains, NY 10605 Phone: 914-997-5904 Fax: 914-682-9100 | |
Dr. Salah M Mesad, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 333 Westchester Ave, Suite 104e, White Plains, NY 10604 Phone: 914-428-9213 Fax: 914-428-9282 |